BioCube Financials

BICB Stock  USD 0.0001  0.00  0.00%   
We suggest to use BioCube fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if BioCube is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to break down twenty-two available fundamental indicators for BioCube, which can be compared to its peers. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of BioCube to be traded at $1.0E-4 in 90 days.
  
Understanding current and past BioCube Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioCube's financial statements are interrelated, with each one affecting the others. For example, an increase in BioCube's assets may result in an increase in income on the income statement.
Please note, the presentation of BioCube's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioCube's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BioCube's management manipulating its earnings.

BioCube Stock Summary

BioCube, Inc., a development stage company, focuses on the development and marketing of lithium ion batteries in North America. The company was formerly known as Alliance Network Communications Holdings, Inc. and changed its name to BioCube, Inc. in December 2010. Biocube is traded on OTC Exchange in the United States.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
ISINUS09056U1079
Business Address1531 Smithtown Avenue,
SectorFinancial Services
IndustryShell Companies
BenchmarkDow Jones Industrial
Phone888 827 7901
CurrencyUSD - US Dollar

BioCube Key Financial Ratios

BioCube's financial ratios allow both analysts and investors to convert raw data from BioCube's financial statements into concise, actionable information that can be used to evaluate the performance of BioCube over time and compare it to other companies across industries.

BioCube Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BioCube's current stock value. Our valuation model uses many indicators to compare BioCube value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioCube competition to find correlations between indicators driving BioCube's intrinsic value. More Info.
BioCube is rated fourth in current valuation category among its peers. It is number one stock in shares outstanding category among its peers creating about  11.69  of Shares Outstanding per Current Valuation. Comparative valuation analysis is a catch-all model that can be used if you cannot value BioCube by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioCube's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

BioCube January 27, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of BioCube help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioCube. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioCube based on widely used predictive technical indicators. In general, we focus on analyzing BioCube Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioCube's daily price indicators and compare them against related drivers.

Complementary Tools for BioCube Pink Sheet analysis

When running BioCube's price analysis, check to measure BioCube's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCube is operating at the current time. Most of BioCube's value examination focuses on studying past and present price action to predict the probability of BioCube's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCube's price. Additionally, you may evaluate how the addition of BioCube to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities